Clinical trial
Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye
NCT00063765 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00063765 |
|---|---|
| Title | Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye |
| Official title | A Phase I Study of NT-501-10 and NT-501-6A.02, Implants of Encapsulated Human NTC-210 Cells Releasing Ciliary Neurotrophic Factor (CNTF), in Patients With Retinitis Pigmentosa |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Retinitis Pigmentosa |
| Intervention type | Drug |
| Interventions | Ciliary Neurotrophic Factor Implant NT-501 |
| Enrollment | 10 |
| Start date | Jun 1, 2003 |
| Completion | Mar 1, 2006 |
| First posted | Jul 4, 2003 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: